# FDA recall D-0926-2017

> **Sanofi-Aventis U.S. LLC** · Class III · drug recall initiated 2017-06-12.

## Product

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P.,  Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

## Reason for recall

Superpotent Drug: high out-of-specification result for magnesium.

## Distribution

Nationwide in the USA, Puerto Rico, and the United Kingdom.

## Key facts

- **Recall number:** D-0926-2017
- **Recalling firm:** Sanofi-Aventis U.S. LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-12
- **Report date:** 2017-07-05
- **Termination date:** 2019-02-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bridgewater, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0926-2017

## Citation

> AI Analytics. FDA recall D-0926-2017. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0926-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*